摘要
饮食和肠道微生物在阿尔茨海默氏症等神经退行性疾病的病理生理学中的作用最近受到了广泛的研究。研究表明人类肠道微生物区系可能有助于调节多种神经化学和神经代谢途径,通过与中枢神经系统相互作用和相互联系的复杂系统。脑和肠fORM是双向通讯轴,反之亦然,它们通过内分泌和复杂免疫系统之间的双向通讯形成轴,涉及神经递质和激素。AB型总之,研究表明,失调和多样化较差的微生物区系可能会干扰神经营养因子的合成和分泌,例如脑源性神经营养因子(Gammaaminob)。苹果酸和N-甲基D-天冬氨酸受体,广泛与认知功能减退和痴呆相关。在此背景下,本文回顾了关于gutbr作用的文献。阿尔茨海默病的AIN轴。
关键词: 大脑,中枢神经系统,肠道,微生物,肠道微生物,老年痴呆症。
Current Alzheimer Research
Title:Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease
Volume: 15 Issue: 13
关键词: 大脑,中枢神经系统,肠道,微生物,肠道微生物,老年痴呆症。
摘要: The role of diet and gut microbiota in the pathophysiology of neurodegenerative diseases, such as Alzheimer's, has recently come under intense investigation. Studies suggest that human gut microbiota may contribute to the modulation of several neurochemical and neurometabolic pathways, through complex systems that interact and interconnect with the central nervous system. The brain and intestine form a bidirectional communication axis, or vice versa, they form an axis through bi-directional communication between endocrine and complex immune systems, involving neurotransmitters and hormones. Above all, studies suggest that dysbiotic and poorly diversified microbiota may interfere with the synthesis and secretion of neurotrophic factors, such as brain-derived neurotrophic factor, gammaaminobutyric acid and N-methyl D-Aspartate receptors, widely associated with cognitive decline and dementia. In this context, the present article provides a review of the literature on the role of the gutbrain axis in Alzheimer's disease.
Export Options
About this article
Cite this article as:
Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease, Current Alzheimer Research 2018; 15 (13) . https://dx.doi.org/10.2174/1567205015666180904155908
DOI https://dx.doi.org/10.2174/1567205015666180904155908 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets An Effective Brain Imaging Biomarker for AD and aMCI: ALFF in Slow-5 Frequency Band
Current Alzheimer Research Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence
Protein & Peptide Letters Platelets and Vascular Risk: An Option for Treatment
Current Pharmaceutical Design Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
Current Pharmaceutical Design Antioxidants in the Treatment of Diabetes
Current Diabetes Reviews Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities
Current Pharmaceutical Design Activation of Brain Endothelium by Soluble Aggregates of the Amyloid-β Protein Involves Nuclear Factor-κB
Current Alzheimer Research Cardiovascular Pharmacogenetics of Anti-Thrombotic Agents and Non-Steroidal Anti-Inflammatory Drugs
Current Molecular Medicine Subcellular Injuries in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Bottom-Up Proteomics
Current Analytical Chemistry M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimers Disease
Current Alzheimer Research Regulation of Gene Expression by TDP-43 and FUS/TLS in Frontotemporal Lobar Degeneration
Current Alzheimer Research Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation
CNS & Neurological Disorders - Drug Targets Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease
Current Alzheimer Research The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders
Current Drug Metabolism Cognitive Impairment with Vascular Impairment and Degeneration
Current Neurovascular Research